Spyros Papapetropoulos insider trades

Open-market stock purchases and sales by Spyros Papapetropoulos, President and CEO at Neuphoria Therapeutics Inc, from SEC Form 4 filings since Apr 11, 2022.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • NEUP Neuphoria Therapeutics Inc: other filings, last Aug 27, 2025
  • LPCN Lipocine Inc: 1 buy, last Jun 4, 2025
  • VIGL Vigil Neuroscience, Inc: 1 buy, 1 sale, last Nov 18, 2022

Get free alerts when Spyros Papapetropoulos files a new trade →